Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries

Health and Quality of Life Outcomes

Volumn 4, Issue , 2006, Pages

  Flood, Emuella M ^a   De Cock, Erwin ^a   Mörk, Ann Christin ^b   Revicki, Dennis A ^a  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; ASTHMA; ASTHMA SYMPTOM UTILITY INDEX; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; COUGHING; DATA COLLECTION METHOD; DISEASE SEVERITY; DYSPNEA; EUROPE; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HEALTH STATUS; HUMAN; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; UNITED KINGDOM; VISUAL ANALOG SCALE; WHEEZING;

ADULT; ALGORITHMS; ASTHMA; CROSS-CULTURAL COMPARISON; FEMALE; FRANCE; GREAT BRITAIN; HUMANS; ITALY; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; UNITED STATES;

EID: 33748956162     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-4-51     Document Type: Article

References (23)

1. Junifer EF: Using humanistic health outcomes data in asthma. Pharmacoeconomics 2001, 19 Suppl 2:13-19.
2. Casale TB, Nelson HS, Kemp J, Parasuraman B, Uryniak T, Liljas B: Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthma. Ann Allergy Asthma Immunol 2003, 90:323-330.
3. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA: Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003, 58:211-216.
4. Thoonen BP, Schermer TR, Van Den Boom G, Molema J, Folgering H, Akkermans RP, Grol R, Van Weel C, Van Schayck CP: Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax 2003, 58:30-36.
5. Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P: Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest 2002, 121:1824-1832.
6. Sculpher MJ, Buxton MJ: The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy. Pharmacoeconomics 1993, 4:345-352.
7. Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A: Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998, 114:998-1007.
8. Bennett KJ, Torrance GW: Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In Quality of life and pharmacoeconomics in clinical trials 2nd edition. Philadelphia, Lippincott-Raven; 1996:253-266.
9. Torrance GW: Measurement of health state utilities for economic appraisal. J Health Econ 1986, 5:1-30.
10. Global Initiative for Asthma; Pocket Guide for Asthma Management and Prevention, NIH Publication No. 02-3659A [http://www.ginasthma.com]
11. Acquadro C, Conway K, Giroudet C, Mear I: Linguistic validation manual for patient-reported outcomes (PRO) instruments. Lyon, France, MAPI Research Institute; 2004.
12. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR: Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902-907.
13. Bonomi AE, Cella DF, Hahn EA, Bjordal K, Sperner-Unterweger B, Gangeri L, Bergman B, Willems-Groot J, Hanquet P, Zittoun R: Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Qual Life Res 1996, 5:309-320.
14. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK: Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992, 47:76-83.
15. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE: Measuring quality of life in asthma. Am Rev Respir Dis 1993, 147:832-838.
16. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR: Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999, 115:1265-1270.
17. Juniper EF, Guyatt GH, Willan A, Griffith LE: Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994, 47:81-87.
18. Furlong WJ, Feeny DH, Torrance GW, Barr RD, Horsman J: Guide to design and development of health-state utility instrumentation. Hamilton, Canada, McMaster University Centre for Health Economics and Policy Analysis Working Paper 90-9; 1990.
19. Torrance GW, Boyle MH, Horwood SP: Application of multiattribute utility theory to measure social preferences for health states. Oper Res 1982, 30:1043-1069.
20. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q: Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care 1996, 34:702-722.
21. Revicki DA, Kaplan RM: Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993, 2:477-487.
22. Juniper EF, Norman GR, Cox FM, Roberts JN: Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001, 18:38-44.
23. Blumenschein K, Johannesson M: Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998, 80:189-194.